- Home
- STRR vs NLSP Comparison
STRR vs NLSP Comparison
Compare STRR & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRR
- NLSP
- Stock Information
- Founded
- STRR 1985
- NLSP 2015
- Country
- STRR United States
- NLSP Switzerland
- Employees
- STRR N/A
- NLSP N/A
- Industry
- STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- STRR Health Care
- NLSP Health Care
- Exchange
- STRR Nasdaq
- NLSP Nasdaq
- Market Cap
- STRR 7.0M
- NLSP 6.2M
- IPO Year
- STRR N/A
- NLSP 2021
- Fundamental
- Price
- STRR $2.28
- NLSP $2.16
- Analyst Decision
- STRR
- NLSP
- Analyst Count
- STRR 0
- NLSP 0
- Target Price
- STRR N/A
- NLSP N/A
- AVG Volume (30 Days)
- STRR 22.9K
- NLSP 1.4M
- Earning Date
- STRR 11-19-2024
- NLSP 01-14-2025
- Dividend Yield
- STRR N/A
- NLSP N/A
- EPS Growth
- STRR N/A
- NLSP N/A
- EPS
- STRR N/A
- NLSP N/A
- Revenue
- STRR $50,375,000.00
- NLSP N/A
- Revenue This Year
- STRR $15.58
- NLSP N/A
- Revenue Next Year
- STRR $36.27
- NLSP N/A
- P/E Ratio
- STRR N/A
- NLSP N/A
- Revenue Growth
- STRR 2.22
- NLSP N/A
- 52 Week Low
- STRR $2.06
- NLSP $1.73
- 52 Week High
- STRR $5.35
- NLSP $23.60
- Technical
- Relative Strength Index (RSI)
- STRR 39.15
- NLSP 45.02
- Support Level
- STRR $2.13
- NLSP $2.07
- Resistance Level
- STRR $2.43
- NLSP $2.95
- Average True Range (ATR)
- STRR 0.16
- NLSP 0.31
- MACD
- STRR 0.03
- NLSP 0.10
- Stochastic Oscillator
- STRR 34.37
- NLSP 35.25
About STRR Star Equity Holdings Inc.
Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.